Know Cancer

or
forgot password

A Randomized Trial of Follow-up Strategies in Breast Cancer


Phase 4
N/A
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

A Randomized Trial of Follow-up Strategies in Breast Cancer


see above


Inclusion Criteria:



- Women with breast cancer on well follow-up at regional cancer centres in Ontario and
Manitoba

- Diagnosed at least 12 months previously (range 9-15 months)

- Without evidence of active disease (i.e., stages IIIB and IV excluded)

- Free from any primary treatment complications

Exclusion Criteria:

- Primary treatment at least 3 months previously, except for continued use of tamoxifen

- Still experiencing complications of primary treatment (patients will become eligible
once complications resolve provided they are within the 6 month window)

- Unable to identify an acceptable family physician to provide follow-up

- Language or literacy skills inconsistent with completing questionnaires

- Unable to comply with study protocol including completion of questionnaires

- Previously enrolled in a study which requires continued follow-up in specialist or
peripheral clinics

- Actively followed at a cancer centre for another primary cancer

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Rate of clinically catastrophic events

Outcome Time Frame:

Up to 5 yrs after randomization

Principal Investigator

Eva Grunfeld, MD

Investigator Role:

Study Chair

Investigator Affiliation:

Cancer Care Nova Scotia

Authority:

Canada: Health Canada

Study ID:

OCOG-1997-FUP

NCT ID:

NCT00156039

Start Date:

January 1997

Completion Date:

June 2003

Related Keywords:

  • Breast Cancer
  • Breast Cancer
  • Follow-up Strategy
  • Follow-up Care
  • Family Physician
  • Oncologist
  • Breast Neoplasms

Name

Location